Skip to content
All Podcasts – Lifestyle
Author:
Lakefront Biotherapeutics
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
August 28, 2026
Acquisition of Own Shares
August 18, 2026
Acquisition of Own Shares
August 12, 2026
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
August 10, 2026
Acquisition of Own Shares
August 4, 2026
Acquisition of Own Shares
July 28, 2026
Acquisition of Own Shares
July 21, 2026
Acquisition of Own Shares
July 14, 2026
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
July 13, 2026
Acquisition of Own Shares
July 7, 2026
←
Previous Page
1
2
3
Next Page
→